XML 22 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2021
Cash flows from operating activities:      
Net earnings $ 3,263 $ 3,132 $ 6,541
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 850 780 785
Stock-based compensation expense 438 343 330
Restructuring and other charges 527 218 251
Deferred taxes on earnings (923) 577 (582)
Defined benefit plan settlement gains 0 0 (37)
Other, net (10) 475 440
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable 278 1,285 (105)
Inventory 668 214 (2,180)
Accounts payable (1,240) (909) 1,257
Net investment in leases (110) (155) (111)
Taxes on earnings 198 (134) 59
Restructuring and other (310) (245) (205)
Other assets and liabilities (58) (1,118) (34)
Net cash provided by operating activities 3,571 4,463 6,409
Cash flows from investing activities:      
Investment in property, plant and equipment (609) (791) (582)
Proceeds from sale of property, plant and equipment 16 26 0
Purchases of available-for-sale securities and other investments (11) (52) (28)
Maturities and sales of available-for-sale securities and other investments 21 9 304
Collateral posted for derivative instruments 0 14 148
Payments made in connection with business acquisitions, net of cash acquired (7) (2,755) (854)
Net cash used in investing activities (590) (3,549) (1,012)
Cash flows from financing activities:      
(Payments of) Proceeds from short-term borrowings with original maturities less than 90 days, net     400
(Payments of) Proceeds from short-term borrowings with original maturities less than 90 days, net 10 400  
Proceeds from debt, net of issuance costs 255 4,175 2,121
Payment of debt (1,700) (693) (1,245)
Stock-based award activities and others (99) (95) (51)
Repurchase of common stock (100) (4,297) (6,249)
Cash dividends paid (1,037) (1,037) (938)
Collateral withdrawn for derivative instruments (200) 200 0
Settlement of cash flow hedges (3)    
Settlement of cash flow hedges   79 0
Net cash used in financing activities (2,894) (2,068) (5,962)
Increase (decrease) in cash, cash equivalents and restricted cash 87 (1,154) (565)
Cash, cash equivalents and restricted cash at beginning of period 3,145 4,299 4,864
Cash, cash equivalents and restricted cash at end of period 3,232 3,145 4,299
Supplemental cash flow disclosures:      
Income taxes paid, net of refunds 398 749 1,548
Interest expense paid $ 548 $ 305 $ 261